中国专家关于加强2型糖尿病个性化防治的共识
Consensus of Chinese experts on strengthening personalized prevention and treatment of type 2 diabetes.
作者信息
Lu Bin, Sun Jianqin, Chen Lili, Song Xiaoyan, Deng Yanbei, Dong Yanhu, Dong Jixiang, Du Peiyi, Ge Jiapu, Guo Yongqiang, Han Peng, Ji Linong, Li Qiang, Li Yuzhong, Liu Chao, Liu Jing, Liu Jie, Lu Juming, Shen Xuanmei, Wan Limei, Wang Zhili, Wang Quansheng, Wu Sen, Xu Mingzhi, Xu Yancheng, Xue Yaoming, Yuan Chun, Yang Yuzhi, Zheng Feng, Zhuo Guojin, Zhang Lei, Zhang Qiu, Zhu Shuiwang, Zhao Zhigang, Weng Jianping, Zhu Dalong, Hu Renming
机构信息
Department of Endocrinology, Huashan Hospital Fudan University, China; Institute of Endocrinology and Diabetology, Fudan University, China.
Department of Clinical Nutrition, Huadong Hospital Fudan University, China.
出版信息
Prim Care Diabetes. 2023 Apr;17(2):137-140. doi: 10.1016/j.pcd.2023.01.003. Epub 2023 Jan 26.
Up to now, there has not yet been guidance or consensus from Chinese experts in the field of personalized prevention and treatment of type 2 diabetes. In view of the above, the endocrinology diabetes Professional Committee of Chinese Non-government Medical Institutions Association, the integrated endocrinology diabetes Professional Committee of the integrated medicine branch of Chinese Medical Doctor Association, and the diabetes education and microvascular complications group of the diabetes branch of the Chinese Medical Association organized relevant experts to discuss and reach the "Chinese expert consensus on strengthening personalized prevention and treatment of type 2 diabetes" for reference in clinical practice.
迄今为止，中国2型糖尿病个性化防治领域尚未有专家指导意见或共识。鉴于此，中国非公立医疗机构协会内分泌糖尿病专业委员会、中国医师协会中西医结合医师分会整合医学内分泌糖尿病专业委员会、中华医学会糖尿病学分会糖尿病教育与微血管并发症学组组织相关专家进行讨论，达成了《中国加强2型糖尿病个性化防治专家共识》，供临床实践参考。
Zotero 插件